USPTO serial 79265240
IMCHECK THERAPEUTICS
Reviewed by CopyMark Law Group
Reg. 6015896Status 708Registered
- Filing date
- Status date
- Registration date
- Mar 24, 2020
- Examiner
- MCCAULEY, BRENDAN D
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with IMCHECK THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ben Natter
Ben Natter Haug Partners, LLP745 Fifth AvenueNew York, NY 10151United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceutical and veterinary products, namely, veterinary pharmaceutical preparations for the prevention of autoimmune diseases and cancer, dermatological pharmaceutical products, and anti-infective products for veterinary use; medical and veterinary preparations, namely, diagnostic preparations for medical or veterinary purposes, and bacterial preparations for medical and veterinary use; biotechnological preparations for medical use, namely, biological preparations for the treatment of cancer and biological preparation for use in cell cultures other than for medical or veterinary use; chemical preparations for medical or pharmaceutical use, namely, for treatment of autoimmune diseases and cancer; sanitary products for medical purposes, namely, sanitary towels, sanitary napkins, sanitary tampons, sanitary pads, sanitary sterilizing preparations and sanitary preparations for medical use; vaccines; antibiotics; adjuvants for medical use; pharmaceutical preparations and substances for treatment of diseases and disorders, namely, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; biological substances for human medical diagnostics and analysis, namely, medical diagnostic reagents and diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; cultures and preparations of microorganisms for medical use; bacterial preparations for medical use; bacteriological preparations for medical use; biological preparations for medical use, namely, biological preparation for use in cell cultures other than for medical or veterinary use; pharmaceutical preparations for medical use, namely, pharmaceutical preparations for wounds, pharmaceutical preparations for skin care, and pharmaceutical preparations for treating allergies; stem cells for medical use; chemical preparations for medical use, namely, chemical preparations for sanitary use and chemical preparations for the diagnosis of pregnancy; enzyme preparations for medical use; dietetic foods for medical use, and dietetic substances for medical use, namely, diet pills and dietetic infusions for medical use; materials for dressings for medical purposes, namely, burn dressings, bandages for dressings, gauze for dressings, wound dressings, wadding for dressings, and medical dressings; material for dental fillings and dental impressions; disinfectants for medical use; disinfectants for medical or sanitary use, other than soaps; bath preparations for medical use; sanitary panties or napkins; medicinal herbs; herbal teas for medicinal purposes; parasiticides for medical use ] | SECTION 71 - CANCELLED | — |
| 041 | Organization and conducting of educational conferences; organization and conducting of seminars and educational colloquiums; organization and conducting of educational symposiums; organization of educational exhibitions; organization of educational meetings in the field of education and training; training courses concerning research and development in the field of cancer [ , autoimmune diseases and immunotherapy; organization of special events in the nature of award ceremonies for providing recognition by the way of awards to demonstrate excellence in the field of research and treatment of cancer, autoimmune diseases and immunotherapy; copyediting of medical publications; publication of printed matter; publication of texts other than advertising texts; electronic publication of books and journals online ] | ACTIVE | — |
| 042 | Scientific research and technical research in the field of pharmaceutical studies; [ evaluations and assessments in the fields of science and technology provided by engineers, namely, product quality evaluation for scientific and technological products provided by engineers; ] information relating to scientific research, namely, providing scientific research information in the field of cancer, autoimmune diseases and immunotherapy; medical research; [ biological research; clinical research in the nature of medical and scientific research, namely, conducting clinical trials for others; ] pharmaceutical research and product development research in the field of pharmaceutical products; [ scientific research in the field of chemistry and biochemistry; biotechnological research; medical research in the field of genetics; ] research and development for products in the medical field; providing scientific research services; [ scientific research services on behalf of third parties; ] medical research in the nature of analysis of human tissues for the purposes of medical research; [ research and development in the field of pharmaceuticals and biotechnology; scientific research in the field of molecular science; scientific research in the field of genetics; scientific research in the field of toxicity tests for scientific research purposes; providing advice with respect to scientific and medical research in the field of immunology and immunotherapy; ] analysis and research services in laboratories, namely, DNA analysis services for scientific research purposes, biological research, and chemical analysis; scientific laboratory services; medical research laboratory services, namely, medical research; [ provision of information in connection with medical and scientific research in the field of pharmaceutical products and clinical trials; conducting medical, pharmaceutical and scientific study programs, namely, conducting clinical trials for others; ] conducting clinical analyses and studies, namely, medical and scientific research in the nature of conducting clinical trials for others; laboratory testing services, namely, material testing and product testing; [ conducting clinical trials for others; conducting clinical trials for others in the fields of medicines, molecules and medical devices; ] providing information with respect to medical research | ACTIVE | — |
| 044 | Laboratory analysis services relating to the treatment of persons, namely, medical analysis services for the diagnosis of cancer; medical laboratory services for sample analysis, namely, medical sample analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services with respect to the treatment of persons provided by laboratories, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; [ medical services; medical diagnostic testing, monitoring and reporting services and medical therapy services, namely, physical therapy services and occupational therapy services; veterinary services; pharmaceutical advice; medical services in the nature of immunotherapy treatments; preparation and dispensing of medication; providing cancer screening services; ] providing medical information in the field of oncology [ and immunotherapy treatments; ] providing medical information; [ providing medical assistance; ] providing medical advice in the field of cancer [ , autoimmune diseases and immunotherapy ] ; medical information; information relating to health, namely, providing health information; advisory services relating to health, namely, consulting services in the field of health | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by IMCHECK THERAPEUTICS
- Other trademarks owned by IMCHECK THERAPEUTICS
- Other trademarks owned by IMCHECK THERAPEUTICS
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named IMCHECK THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 14, 2026 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jul 14, 2026 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jun 29, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 29, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 4, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 17, 2026 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Mar 24, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 22, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 22, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 22, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 22, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 25, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 4, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 4, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 24, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 24, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 7, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 7, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 4, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 18, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 18, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 18, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 4, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 3, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 22, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 21, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 21, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 28, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 11, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 11, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 31, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 31, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 30, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 27, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 27, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 15, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |